Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-Ketamine: Timing of Low-Dose Ketamine in Laparotomy
NCT04462094Completed
- Sponsor
- Udayana University
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in postoperative pain and inflammation, sponsored by Udayana University. Primary endpoint: C-Reactive Protein at 24 hours. Started Jul 2020; status: completed.
02
Drugs
ketamine
03
Conditions
postoperative paininflammation
Beyond the preview
Go deeper on NCT04462094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462094.